Thomas Harrer

Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.

B. Walker, T. Harrer, U. Utz, 1993, Journal of immunology.

Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.

B. Walker, T. Harrer, S. Kalams, 1996, Journal of immunology.

T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant

W. Blattner, B. Walker, T. Harrer, 1996, The Journal of experimental medicine.

Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens

B. Walker, T. Harrer, R. Johnson, 1993, Journal of virology.

Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor.

B. Walker, T. Harrer, S. Buchbinder, 1996, The Journal of infectious diseases.